Search the Newsreel

Great Lakes Advisors LLC Invests $8.15 Million in Jazz Pharmaceuticals PLC $JAZZ

Great Lakes Advisors LLC has acquired a new stake of $8.15 million in Jazz Pharmaceuticals PLC, purchasing 33,804 shares in the second quarter. This move makes Great Lakes Advisors LLC own approximately 0.05% of the company's stock. The article also details recent insider stock …

637,500 Shares in Corvus Pharmaceuticals, Inc. $CRVS Bought by DCF Advisers LLC

DCF Advisers LLC recently acquired a significant stake of 637,500 shares in Corvus Pharmaceuticals (NASDAQ:CRVS), valued at approximately $9.5 million. This purchase makes Corvus the sixth largest holding in DCF Advisers' portfolio, representing 1.7% of their total assets. The article also notes recent insider …

Eton Pharmaceuticals (NASDAQ:ETON) Reaches New 1-Year High - What's Next?

Eton Pharmaceuticals (NASDAQ:ETON) recently hit a new 52-week high of $63.83, with its stock trading at $61.48. This surge follows positive analyst upgrades and strong quarterly earnings, where the company reported $0.43 EPS, significantly beating estimates, and revenue of $37.59 million. Despite insider stock …

Element Pointe Advisors LLC Invests $836,000 in Thermo Fisher Scientific Inc. $TMO

Element Pointe Advisors LLC acquired a new stake of 1,668 shares, valued at $836,000, in Thermo Fisher Scientific Inc. during the second quarter. Other institutional investors have also increased their holdings, with BlackRock Inc. buying a significant new position worth over $15 billion. The …

First National Bank of Omaha Buys New Position in Thermo Fisher Scientific Inc. $TMO

First National Bank of Omaha has acquired a new position in Thermo Fisher Scientific Inc. (NYSE:TMO), purchasing 27,553 shares valued at approximately $13.895 million. This move is part of broader institutional interest, with several other firms also adjusting their stakes in the medical research …

39,241 Shares in Amylyx Pharmaceuticals, Inc. $AMLX Purchased by GSA Capital Partners LLP

Fermi (FRMI) Earnings Snapshot: EPS Prints Above Forecast on the Day; Trading Move: Shares Finish 0.35% Up at the Close - Operating Income Trends

Crossmark Global Holdings Inc. Sells 3,717 Shares of Meta Platforms, Inc. $META

German American Bancorp Inc. Purchases Shares of 1,230 The Goldman Sachs Group, Inc. $GS

German American Bancorp Inc. recently acquired 1,230 shares of The Goldman Sachs Group, Inc. valued at approximately $1.24 million, marking a new position in the investment management company. Goldman Sachs reported strong quarterly earnings, exceeding consensus estimates, with revenue up 39.4% year over year. …

3,366 Shares in Thermo Fisher Scientific Inc. $TMO Purchased by BOK Financial Private Wealth Inc.

BOK Financial Private Wealth Inc. acquired 3,366 shares of Thermo Fisher Scientific Inc. (NYSE:TMO) for approximately $1.69 million in the second quarter. Institutional investors and hedge funds own 89.23% of the company, which recently reported strong quarterly earnings with $6.03 EPS and $11.99 billion …

Ascentage Pharma H1 Loss Widens, Revenue Rises

KEEL Stock Quote Price and Forecast

Aurora Investment Counsel Takes Position in ANI Pharmaceuticals, Inc. $ANIP

Aurora Investment Counsel has acquired a new stake of 26,890 shares in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) during the second quarter, valued at approximately $2.23 million. This comes as several other institutional investors have also adjusted their holdings in the specialty pharmaceutical company. ANI Pharmaceuticals …

NVLG: Stable revenue, improved margins, and major restructuring amid regional conflict and regulatory actions

NVLG: Q2 2026 revenue grew 2.3% to ₪451.9M, with all segments profitable and strong cash reserves

Algebris UK Ltd. Takes $41.37 Million Position in Fidelity National Information Services, Inc. $FIS

Algebris UK Ltd. has acquired a new position in Fidelity National Information Services (NYSE:FIS) worth approximately $41.37 million, representing 2.7% of its portfolio. This makes FIS the 16th largest holding for Algebris UK Ltd. Other institutional investors have also adjusted their stakes in FIS, …

2,463 Shares in Thermo Fisher Scientific Inc. $TMO Purchased by Alpine Woods Capital Investors LLC

Alpine Woods Capital Investors LLC recently purchased 2,463 shares of Thermo Fisher Scientific (NYSE:TMO) valued at approximately $1.24 million in the second quarter. Other institutional investors have also adjusted their holdings in the company, with institutional investors and hedge funds collectively owning 89.23% of …

Ormat Technologies, Inc. (NYSE:ORA) Receives Average Rating of "Moderate Buy" from Analysts

Ormat Technologies, Inc. (NYSE:ORA) has received an average analyst rating of "Moderate Buy," with an average 12-month price target of $130.83, significantly above its current share price of $110.32. The company recently surpassed quarterly earnings estimates, reporting $0.50 EPS against an estimated $0.26, and …

23,165 Shares in Dorman Products, Inc. $DORM Purchased by Aurora Investment Counsel

Aurora Investment Counsel has acquired 23,165 shares of Dorman Products, Inc. (NASDAQ:DORM) during the second quarter, valuing their new stake at approximately $3.16 million and making it their second-largest position. Other institutional investors also increased their holdings in Dorman Products, while insider trading showed …

How Investors Are Reacting To Aurinia Pharmaceuticals (AUPH) Extended Voclosporin Exclusivity And Share Buyback

Aurinia Pharmaceuticals Inc. recently reported second-quarter 2026 results showing higher revenue and earnings year over year, reiterated its 2026 revenue and net product sales guidance, completed a large share buyback program, and finalized a settlement with Teva Pharmaceuticals that delays U.S. generic voclosporin entry …

Meta faces a $1.4 trillion threat that could mean ‘turning in the keys and walking away’—but the stakes of the case reach across tech

It's no secret Meta is one of the wealthiest companies in the world. Last year, it brought in nearly $201 billion in revenue, and at the end of this June, it was sitting on more than $90 billion in cash and marketable securities. Now, …

Harmoney Surpasses Profit Guidance and Lifts FY27 Outlook

Top Once Upon A Farm (OFRM) Competitors 2026

Benitec (BNTC) Earnings Update: The EPS Result Is Above Expectation for the Current Session; Price Reaction: The Market Price Advances 3.88% in the Latest Reading - Low Growth Earnings

Total debt of SolarMax Technology, Inc. – SWB:6W10

The article focuses on the total debt of SolarMax Technology, Inc., trading under the ticker SWB:6W10 on the Stuttgart Stock Exchange. It provides a financial overview of the company, though the specific debt value is not detailed in the provided content. The page structure …

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Average Rating of "Moderate Buy" from Analysts

Thirteen research firms have given Syndax Pharmaceuticals (NASDAQ:SNDX) an average recommendation of "Moderate Buy," with an average 12-month price target of $41.91. Despite missing Q2 earnings and revenue estimates and insider share sales, institutional investors like BlackRock and Vanguard have increased their stakes. The …

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Consensus Recommendation of "Hold" by Analysts

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) has received a consensus "Hold" rating from ten analysts, with an average 12-month price target of $45.50. The company recently surpassed earnings and revenue expectations, reporting $1.28 adjusted EPS against an estimated $0.96 and a 30.3% year-over-year revenue increase …

Alarm.com (ALRM) Results Review: EPS Exceeds Its Estimate on the Day; Session Move: Shares Close 3.26% Higher in the Latest Session - Banking Earnings Report

Phio Pharmaceuticals (PHIO) Chairman Robert Bitterman Buys 10,00

Phio Pharmaceuticals (PHIO) Chairman Robert Bitterman has purchased an additional 10,000 shares of the company, bringing his total holdings to 431,421 shares. This transaction at $1.06 per share reflects a strong insider sentiment, with 6 insider buys and 0 insider sells over the past …

PermRock Royalty Trust Trust Revenue Breakdown – NYSE:PRT

PermRock Royalty Trust's revenue breakdown shows that the United States is its primary contributor. Last year, the U.S. segment generated $5.61 million, a slight decrease from $6.02 million in the previous year. This data highlights the company's geographical revenue concentration.

REGN Stockholders Interested in Leading the Class Action Against Regeneron Pharmaceuticals, Inc. Should Contact Robbins LLP for Information About Recovering Their Losses

Robbins LLP is reminding investors that a securities class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN). The lawsuit alleges that Regeneron misled investors about its Phase 3 Fianlimab-Libtayo clinical trial for advanced melanoma, specifically regarding statistical assumptions and clinical differentiation. …

Farmiera Q2 Net Profit Rises 13%; Insurance Claim on Fire Still Pending

What's Going On With Firm Capital Property Trust Stock Thursday?

What's Going On With Firm Capital Mortgage Invest Corp Stock Thursday?

CSPC Pharmaceutical's Attributable Profit More Than Doubles in H1; Shares Jump 14%

Meta Platforms stock holds in the mid-$540s as Q2 2026 growth meets legal and cash flow pressures